Beacon Discovery Announces Collaboration With Outpost Medicine

BEACON DISCOVERY ANNOUNCES COLLABORATION WITH OUTPOST MEDICINE

 
Beacon Discovery is happy to announce their collaboration with Outpost Medicine. As a pre-clinical pharmacology expert team, Beacon played a key role in the evaluation of an undisclosed preclinical compound, facilitating the recent licensing agreement between Arena Pharmaceuticals and Outpost Medicine. Outpost will now further advance the compound that has potential utility in treating genitourinary disorders.
 
During their time at Arena, senior Beacon scientists were responsible for leading the discovery and early evaluation of this unique compound and so are particularly pleased to assist in its ongoing development in order to realize its potential as a therapeutic agent. Having key knowledge and expertise around both the licensed compound and its receptor, the Beacon team will continue to work in partnership with Outpost on additional aspects to evaluate the pharmacology and therapeutic potential of this novel compound as they strive to bring an important new treatment to patients.